ProNovo Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A
  • (In Progress)

  • Investors
  • 4

ProNovo General Information

Description

Developer of targeted pharmaceutical treatments designed to address neuropsychiatric conditions. The company's platform utilizes scientific research and technology to create precision therapeutics, enabling healthcare providers to access novel options for the treatment of disorders such as major depressive disorder and schizophrenia, with a focus on addressing clinical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11622 El Camino Real
  • Suite 100
  • San Diego, CA 92130
  • United States
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 11622 El Camino Real
  • Suite 100
  • San Diego, CA 92130
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProNovo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) In Progress Startup
1. Seed Round 15-Apr-2025 Completed Startup
To view ProNovo’s complete valuation and funding history, request access »

ProNovo Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
To view ProNovo’s complete cap table history, request access »

ProNovo Patents

ProNovo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025240620-A1 Selective dual agonists of muscarinic 1 and 4 receptors and therapeutic uses thereof Pending 14-May-2024

ProNovo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProNovo Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
3E Bioventures Capital Venture Capital Minority
Gaorong Ventures Venture Capital Minority
JLS Fund Venture Capital Minority
K2VC Venture Capital Minority
To view ProNovo’s complete investors history, request access »

ProNovo FAQs

  • When was ProNovo founded?

    ProNovo was founded in 2023.

  • Where is ProNovo headquartered?

    ProNovo is headquartered in San Diego, CA.

  • What is the size of ProNovo?

    ProNovo has 2 total employees.

  • What industry is ProNovo in?

    ProNovo’s primary industry is Biotechnology.

  • Is ProNovo a private or public company?

    ProNovo is a Private company.

  • What is the current valuation of ProNovo?

    The current valuation of ProNovo is .

  • What is ProNovo’s current revenue?

    The current revenue for ProNovo is .

  • How much funding has ProNovo raised over time?

    ProNovo has raised $13.5M.

  • Who are ProNovo’s investors?

    3E Bioventures Capital, Gaorong Ventures, JLS Fund, and K2VC have invested in ProNovo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process